RAYMOND DECKER: Open Payments
NPI 1972594828 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 68 payments from 22 companies in 2025. Trend: 2023 $880 · 2024 $1,406 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $187 |
| AstraZeneca Pharmaceuticals LP | 5 | $162 |
| ABBVIE INC. | 13 | $152 |
| PFIZER INC. | 7 | $115 |
| Lilly USA, LLC | 5 | $85 |
| Phathom Pharmaceuticals, Inc. | 5 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Lundbeck LLC | 1 | $22 |
| Abbott Laboratories | 1 | $20 |
Products named: Ozempic, AIRSUPRA, QULIPTA, PREVNAR 20, VOQUEZNA, MOUNJARO, UBRELVY, JARDIANCE.
Industry payments across VA — which companies pay providers there.
